Refractory Ovarian Carcinoma Clinical Trials in Scottsdale, Arizona
2 recruitingScottsdale, Arizona
Showing 1–2 of 2 trials
Recruiting
Phase 1
MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer
Recurrent Ovarian CarcinomaRecurrent Fallopian Tube CarcinomaRecurrent Primary Peritoneal Carcinoma+13 more
Mayo Clinic12 enrolled1 locationNCT06483048
Recruiting
Phase 2
A Study of CBX 12 in Subjects With Platinum Resistant or Refractory Ovarian Cancer
Platinum Resistant Ovarian CancerRefractory Ovarian Carcinoma
Cybrexa Therapeutics40 enrolled17 locationsNCT06315491